Quantum Computing Inc. (QCi) announced on January 15, 2025, a collaboration with Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. (Sanders TDI). This partnership aims to advance research in computational biomedicine by providing Sanders TDI with cloud-based access to QCi's Dirac-3 Entropy Quantum Computing Machine.
Sanders TDI is a non-profit drug discovery institute composed of Kettering Cancer Center, The Rockefeller University, and Memorial Sloan Weill Cornell Medicine, focused on advancing biological discoveries to preclinical studies. The Dirac-3 systems, operating at room temperature and low power, are designed to solve complex optimization problems.
Dr. William McGann, CEO of QCi, stated that this partnership exemplifies how QCi's quantum machines can provide powerful insights and useful analyses today, aligning with the company's mission to make quantum machines accessible and affordable. The collaboration will explore quantum-enabled applications for biomolecular modeling, aiming to identify promising use cases for Dirac systems.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.